Most Recent
Meta, Instagram lose appeal bid to arbitrate startup’s competition case
An appeals court has dismissed a second attempt by Meta and Instagram to shut down a misuse of market power case by a Melbourne-based social media startup.
Court asked to find Retail Food Group class action exempt from MIS rules
A class action against franchise giant Retail Food Group wants to head off any challenge to its funding agreement with a court order that the financing arrangement is exempt from controversial regulations requiring group proceedings to be run as managed investment schemes.
The class action settlements that came under fire in 2021
If evidence were needed that courts are not rubber stamping class action settlements, the scrutiny of multi-million dollar agreements in 2021 is proof positive that judicial oversight of representative proceedings is robust.
Judge shoots down ‘audacious’ McMillan Shakespeare claim for surplus class action funds
A judge has rejected an "audacious" attempt by McMillan Shakespeare to recoup a surplus of funds left over after a $9.5 million class action settlement was distributed to registered group members.
Funder of Qld energy class action takes on MIS rules in appeal
A litigation funder has taken aim at a landmark judgment in an appeal of a ruling that found its funding arrangement with group members in a class action against Queensland energy suppliers was a managed investment scheme.
Mercedes-Benz hits back at $650M lawsuit, says dealer agreements not ‘perpetual’
Mercedes-Benz has responded to a $650 million lawsuit by Australian dealers over its decision to move to a fixed-price agency model, saying it had a "legitimate commercial interest" in making the change and denying that dealer agreements were "perpetual" in their terms.
Dr Reddy’s must warn Celgene of plans to sell generic blockbuster cancer drug
Indian generics giant Dr Reddy’s Laboratories must give Bristol-Myers Squib unit Celgene Corporation three months’ notice before deciding to sell generic versions of blockbuster cancer drug Revlimid in Australia.
Arnold Bloch Leibler to pay $28M in class action settlement
Law firm Arnold Bloch Leibler will part with $28 million in its settlement with Slater & Gordon shareholders over advice ahead of the plaintiffs firm's disastrous $1.2 billion Quindell acquisition.
Lawyers, funder want 35% cut of $125M Crown class action settlement
The lawyers and funder behind a shareholder class action against Crown Resorts will be asking the court to approve fees and commission worth 35 per cent of a $125 million settlement with the gaming giant, leaving over $81 million for group members.
Judge questions why fees, commission missing from Crown settlement notice
A judge has directed that the legal fees and funding commission sought to be deducted from a $125 million class action settlement with Crown Resorts be included in a proposed notice to shareholders, after learning that group members were forced to click through to Maurice Blackburn's website to find the "critical" figures.